… of antithrombotic therapy (… , therapy) are guided by the clinical context and the COVID-19
severity. We provide a practical approach on antithrombotic therapy management for COVID-19 …

… We included studies of adults with COVID-19 that examined … outcomes with use of
antithrombotic therapies. We broadly … antithrombotic agents to include anticoagulation therapies (…

… of antithrombotic agents, doses, and durations of therapy are … , and patients critically ill with
COVID-19. This paper provides … related to antithrombotic strategies used in COVID-19, the …

… care related to thrombosis and antithrombotic therapy. Given the … therapeutic anticoagulant
regimens among various subgroups of patients with COVID-19, and antithrombotic therapy …

… and prognosis of hospitalized COVID-19 patients. In the present analysis, antithrombotic
therapy before admission did not influence the clinical presentation COVID-19 in terms of ARDS …

… ‐19 have been conducted and published within a relatively … of antithrombotic treatment
among patients with COVID‐19 … ISTH COVID‐19 Antithrombotic Good Practice Statements. …

… COVID-19 typically receive antithrombotic therapy, although the risks and benefits of this
intervention among outpatients with COVID-19 … anticoagulant or antiplatelet therapy can safely …

… and antiplatelet agents for COVID‐19 patients. The ISTH … in the antithrombotic management
of COVID‐19 patients in … The antithrombotic therapies discussed in these GPS should …

… in the past year of antithrombotic therapy in patients who are … use of antithrombotic therapy
in patients with COVID-19. … from the ongoing antithrombotic COVID-19 studies to guide …

… Other advantage, especially in the setting of COVID-19, … analysis in hospitalized COVID-19
patients (TARGET-COVID Study)… antithrombotic therapy in patients affected by COVID-19 and …